Author Topic: (Abst.) PML and the spectrum of JC virus-related disease  (Read 54 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9480
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) PML and the spectrum of JC virus-related disease
« on: November 22, 2020, 11:44:41 am »
From PubMed (November 22, 2020)--"Progressive multifocal leucoencephalopathy and the spectrum of JC virus-related disease," an abstract of a study appearing in Nature and done by investigators at the National Institutes of Health:

Excerpt from the abstract:

Antiretroviral therapies greatly reduce the risk of HIV-related PML, but many modern treatments for cancers, organ transplantation and chronic inflammatory disease cause immunosuppression that can be difficult to reverse. These treatments - most notably natalizumab for multiple sclerosis - have led to a surge of iatrogenic PML. The spectrum of presentations of JCV-related disease has evolved over time and may challenge current diagnostic criteria. Immunotherapeutic interventions, such as use of checkpoint inhibitors and adoptive T cell transfer, have shown promise but caution is needed in the management of immune reconstitution inflammatory syndrome, an exuberant immune response that can contribute to morbidity and death.[/size] [/color][/size]

[/size][size=78%][Emphasis added][/size]
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.


Related Topics

  Subject / Started by Replies Last post
0 Replies
Last post May 16, 2017, 12:13:10 pm
by agate
1 Replies
Last post December 30, 2018, 03:59:34 pm
by agate
0 Replies
Last post December 11, 2020, 05:49:53 am
by agate
0 Replies
Last post October 25, 2022, 09:20:47 pm
by agate
0 Replies
Last post November 25, 2022, 04:08:18 pm
by agate